An Integrative Analysis Revealing ZFHX4-AS1 as a Novel Prognostic Biomarker Correlated with Immune Infiltrates in Ovarian Cancer

Figure 4

Kaplan–Meier assays for ZFHX4-AS1 in pan-cancer.